The Freedom Stack: Research Applications

Research Applications (Component-Level)

The published work behind each vial in this kit falls into the following areas. Every study listed used a single component, not the stack.

1. Incretin and glucagon receptor pharmacology — retatrutide is the triple-agonist reference compound used to separate the contribution of glucagon-receptor engagement from GIP/GLP-1 agonism.[1][2]
2. Metabolic and hepatic research — phase 2 trials of the pharmaceutical formulation have been published in obesity and type 2 diabetes.[3][4]
3. Mitochondrial bioenergetics — SS-31 is used as a cardiolipin-targeting tool compound in electron-transport and ATP-synthesis studies.[5][7]
4. Cardiac and ageing models — SS-31 has been evaluated in canine heart-failure and aged-mouse paradigms.[9][10]
5. Neurodegeneration models — Zhao et al. examined SS-31 in an Alzheimer's disease model.[11]
6. Tissue-repair and matrix models — the KLOW component peptides have been studied individually in wound-healing, angiogenesis, and matrix-remodeling systems.[12][15][18]
7. Inflammation models — KPV has been examined in murine colitis and inflammatory bowel disease models.[20]

Important: no cited study used the combined stack. Researchers should not assume that single-agent findings carry over to co-administration.